Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E F Hahn

Showing results (31-40 of 53) with videos related to

Pageof 6
Sort By:
AIDS Research and Human Retroviruses|December 1, 1988
Nucleotide dimers suppress HIV expression in vitroM Busso, A M Mian, E F Hahn, et al.
Life Sciences|August 10, 1987
Oxymorphone-naltrexonazine, a mixed opiate agonist-antagonistS Galetta, E F Hahn, S Nishimura, et al.
Biochemical and Biophysical Research Communications|July 30, 1982
Early exposure to naloxone increases blood pressure in normotensive and hypertensive ratsE F Hahn, C P Martucci, J P Gilligan, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1989
Pharmacological actions of a novel mixed opiate agonist/antagonist: naloxone benzoylhydrazoneM A Gistrak, D Paul, E F Hahn, et al.
Lancet (London, England)|February 5, 1983
Naloxone, a specific opioid antagonist, reverses chronic idiopathic constipationM J Kreek, R A Schaefer, E F Hahn, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1985
Irreversible opiate agonists and antagonists. II. Evidence against a bivalent mechanism of action for opiate azines and diacylhydrazonesE F Hahn, S Nishimura, R R Goodman, et al.
Steroids|December 1, 1985
Unexpected effects of nalmefene, a new opiate antagonist, on the hypothalamic-pituitary-gonadal axis in the male ratP Limonta, C W Bardin, E F Hahn, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1977
Orientation of the oxygen atom at C-6 as a determinant of agonistic activity in the oxymorphone seriesA Z Ronai, F F Foldes, E F Hahn, et al.
Life Sciences|January 1, 1988
Irreversible opiate agonists and antagonists: V. Hydrazone and acylhydrazone derivatives of naltrexoneM C Luke, E F Hahn, M Price, et al.
Endocrinology|November 1, 1984
Catechol estrogen formation and metabolism in brain tissue: comparison of tritium release from different positions in ring A of the steroidP H Jellinck, E F Hahn, B I Norton, et al.
Pageof 6

Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
AIDS Research and Human Retroviruses|December 1, 1988
Nucleotide dimers suppress HIV expression in vitroM Busso, A M Mian, E F Hahn, et al.
Life Sciences|August 10, 1987
Oxymorphone-naltrexonazine, a mixed opiate agonist-antagonistS Galetta, E F Hahn, S Nishimura, et al.
Biochemical and Biophysical Research Communications|July 30, 1982
Early exposure to naloxone increases blood pressure in normotensive and hypertensive ratsE F Hahn, C P Martucci, J P Gilligan, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1989
Pharmacological actions of a novel mixed opiate agonist/antagonist: naloxone benzoylhydrazoneM A Gistrak, D Paul, E F Hahn, et al.
Lancet (London, England)|February 5, 1983
Naloxone, a specific opioid antagonist, reverses chronic idiopathic constipationM J Kreek, R A Schaefer, E F Hahn, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1985
Irreversible opiate agonists and antagonists. II. Evidence against a bivalent mechanism of action for opiate azines and diacylhydrazonesE F Hahn, S Nishimura, R R Goodman, et al.
Steroids|December 1, 1985
Unexpected effects of nalmefene, a new opiate antagonist, on the hypothalamic-pituitary-gonadal axis in the male ratP Limonta, C W Bardin, E F Hahn, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1977
Orientation of the oxygen atom at C-6 as a determinant of agonistic activity in the oxymorphone seriesA Z Ronai, F F Foldes, E F Hahn, et al.
Life Sciences|January 1, 1988
Irreversible opiate agonists and antagonists: V. Hydrazone and acylhydrazone derivatives of naltrexoneM C Luke, E F Hahn, M Price, et al.
Endocrinology|November 1, 1984
Catechol estrogen formation and metabolism in brain tissue: comparison of tritium release from different positions in ring A of the steroidP H Jellinck, E F Hahn, B I Norton, et al.
Pageof 6